Literature DB >> 6488314

Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.

T A Stewart, P K Pattengale, P Leder.   

Abstract

We have produced 13 strains of transgenic mice that carry an otherwise normal mouse myc gene in which increasingly larger portions of the myc promoter region have been replaced by a hormonally inducible mouse mammary tumor virus promoter. Although expression of the fusion genes varies among these animals, the female founders of two of these transgenic strains spontaneously developed mammary adenocarcinomas during one of their early pregnancies. Both the tumors and the breast tissue of these founder animals expressed RNA transcripts corresponding to the fusion gene. Furthermore, in the best studied strain, all the available F1 female progeny that inherited the MTV/myc gene also developed mammary adenocarcinomas during their second or third pregnancies. Thus, although it has no obvious effect on the early development of these mice, the constitutionally deregulated myc gene appears to act as a heritable, predisposing factor favoring the accelerated development of a tissue-specific adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6488314     DOI: 10.1016/0092-8674(84)90257-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  254 in total

Review 1.  Intellectual property law: a primer for scientists.

Authors:  William M Brown
Journal:  Mol Biotechnol       Date:  2003-03       Impact factor: 2.695

2.  Genes involved in breast cancer progression: analysis of global changes in gene expression or retroviral tagging?

Authors:  Emmett V Schmidt
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  A transgenic, mesodermal specific, Dkk1 mouse model recapitulates a spectrum of human congenital limb reduction defects.

Authors:  Filemon Dela Cruz; Melissa Terry; Igor Matushansky
Journal:  Differentiation       Date:  2012-03-08       Impact factor: 3.880

4.  Downregulation of JE and KC genes by glucocorticoids does not prevent the G0----G1 transition in BALB/3T3 cells.

Authors:  L E Rameh; M C Armelin
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

Review 5.  Interrogating mouse mammary cancer models: insights from gene expression profiling.

Authors:  Antonio A Fargiano; Kartiki V Desai; Jeffrey E Green
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

6.  Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells.

Authors:  M D Sklar; E Thompson; M J Welsh; M Liebert; J Harney; H B Grossman; M Smith; E V Prochownik
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

7.  Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model.

Authors:  E V Schmidt; P K Pattengale; L Weir; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo.

Authors:  Rainer B Lanz; Steven S Chua; Niall Barron; Bettina M Söder; Francesco DeMayo; Bert W O'Malley
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

Review 9.  Cyclins and breast cancer.

Authors:  Robert L Sutherland; Elizabeth A Musgrove
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

Review 10.  Of mice and Myc: c-Myc and mammary tumorigenesis.

Authors:  M Hunter Jamerson; Michael D Johnson; Robert B Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.